Israel Archives

Podcast 18 Aug 2023

Beyond Biotech podcast 59 – World Lung Cancer Day

Since its inception in 2012, World Lung Cancer Day has been observed every year on August 1 in order to raise awareness of lung cancer issues and magnify the need for more lung cancer research funding. Around a quarter of a million people in the US alone will be diagnosed with some form of lung […]

August 18, 2023

News and Trends 20 Jul 2023

Biomica announces interim positive results from irritable bowel syndrome program

Biomica Ltd., a clinical-stage biopharmaceutical company developing microbiome-based therapeutics, has released interim positive results from pre-clinical studies in its irritable bowel syndrome (IBS) program. The work was performed in collaboration with the lab of Kara Gross Margolis, associate director for clinical and translational research for the New York University Pain Research Center and an associate […]

July 20, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 24 Apr 2023

RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models

Researchers from Tel Aviv University in Israel have revealed details of a new approach to the treatment of ovarian cancer using RNA-based nanodrugs – demonstrating an 80% survival rate in lab models.In a study at Tel Aviv University, the protein CKAP5 (cytoskeleton-associated protein) was used for the first time as a therapeutic target for RNA-based […]

April 24, 2023 - 4 minutesmins - By Jim Cornall

CAR-T cell therapy, cancer therapy, cell therapy

Interview 17 Feb 2023

The benefits – and challenges – of in-house CAR T-cell therapy

The Sheba Medical Center in Israel has an advanced hemato-oncology center that offers in-house CAR T-cell therapy, the revolutionary immunotherapy that alters a patient’s white blood cells to kill cancer cells. By keeping the entire process at the hospital, and not sending the cells to an external lab, the quality of the T-cells are better […]

February 17, 2023 - 5 minutesmins - By Jim Cornall

Interview 26 Jan 2023

Scopio on the future of telehematology

Through full-field digital cell morphology, Scopio Labs’ technology can automate the analysis of tens of thousands of cells at a time. This could mean bringing earlier detection and diagnosis of cancers, infections, and other diseases, expediting patients’ access to better care and life-saving treatments. Erez Na’aman, co-founder and CTO of Scopio Labs, tells us about […]

January 26, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 21 Dec 2022

Biomica raises $20M to advance microbiome-based therapeutics pipeline

Biomica Ltd., a subsidiary of Evogene Ltd., has signed a definitive agreement for a $20 million financing round, to be led by Shanghai Healthcare Capital (SHC). The financing is subject to customary closing conditions, including clearance by Chinese regulatory authorities. The financing round will enable Biomica to develop its pipeline of microbiome-based therapeutics. The company […]

December 21, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 14 Dec 2022

OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023

Ofer Sharon is the CEO of OncoHost, a biotech company in the precision oncology space. A physician by training, Sharon has leveraged his experience in pharma drug development and entrepreneurship to lead OncoHost through the development of PROphet, the company’s host response profiling platform, which will launch in the U.S. for non-small cell lung cancer […]

December 14, 2022 - 7 minutesmins - By Jim Cornall

News and Trends 18 Nov 2022

MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma

KAHR Medical, a clinical stage biotech company that is developing a treatment for solid tumors and blood cancers has received investment from the Myeloma Investment Fund (MIF). MIF has made the investment to explore the potential of DSP107, KAHR’s leading immunotherapy drug candidate for the treatment of multiple myeloma. “We are thrilled to partner with […]

November 18, 2022 - 3 minutesmins - By Liza Laws

News and Trends 16 Nov 2022

Foodtech company, Wilk, creates first cultured milk fat, cell-based yogurt

Israeli company, Wilk, has today (November 16) announced the successful development of the world’s first yogurt developed with cell-cultured milk fat. The company is a developer of cell-cultured human and animal milk and milk components and this hybrid product has been validated by external laboratories, which Wilk says confirms it meets the necessary chemical and […]

November 16, 2022 - 2 minutesmins - By Liza Laws

Better Juice Launches Commercial Sugar Reduction Plant 002

More News! 9 Nov 2022

Better Juice launches naturally converting fruit juice sugars to prebiotics

A new site housing technology to naturally turn the composition of fruit juice sugars including sucrose, glucose and fructose into better-for-you prebiotics has been opened by Better Juice Ltd. The Israeli sugar-reduction startup launched its first full-capacity manufacturing plant for full commercial production of sugar-reducing immobilized enzymes. The new facility, the company says, will allow […]

November 9, 2022 - 4 minutesmins - By Liza Laws

News and Trends 31 Oct 2022

Startup BioRaptor raises $3M to drive AI insights for scientists

BioRaptor has raised $3M in funding, which it says will allow it to put the power of AI-generated insights into the hands of every scientist. The round was led by lool Ventures and CPT Capital and was joined by FoodHack and other strategic angel investors. BioRaptor is building an operating system for biology research and […]

October 31, 2022 - 2 minutesmins - By Jim Cornall

Forsea Foods is relieving bottleneck in seafood supply starting with eel meat

News and Trends 26 Oct 2022

Forsea Foods raises $5.2M in bid to redress destruction of marine life

With eels becoming an endangered species and demand for its meat continuing to increase, the Israeli food-tech startup Forsea Foods has raised $5.2 million in a seed round to address the issue. Forsea Foods Ltd. is the first company to use organoid technology for culturing seafood products. Its aim is to redress the destruction of […]

October 26, 2022 - 4 minutesmins - By Liza Laws

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Israel

Beyond Biotech podcast 59 – World Lung Cancer Day

Biomica announces interim positive results from irritable bowel syndrome program

RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models

The benefits – and challenges – of in-house CAR T-cell therapy

Scopio on the future of telehematology

Biomica raises $20M to advance microbiome-based therapeutics pipeline

OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023

MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma

Foodtech company, Wilk, creates first cultured milk fat, cell-based yogurt

Better Juice launches naturally converting fruit juice sugars to prebiotics

Startup BioRaptor raises $3M to drive AI insights for scientists

Forsea Foods raises $5.2M in bid to redress destruction of marine life

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!